Dimed S.A. Distribuidora de Medicamentos
B3:PNVL3.SA
10.02 (BRL) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) BRL.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 4,461.017 | 3,990.475 | 3,225.408 | 2,819.11 | 2,724.68 | 2,432.246 | 2,258.246 | 4,257.464 | 1,986.026 | 1,887.076 | 3,480.84 | 1,524 | 1,345.632 | 1,190.659 | 1,074.63 | 933.239 | 832.805 | 733.526 |
Cost of Revenue
| 3,282.894 | 2,747.937 | 2,236.809 | 1,995.415 | 1,915.767 | 1,716.252 | 1,721.736 | 1,608.447 | 1,534.454 | 1,467.67 | 1,358.399 | 1,181.278 | 1,055.199 | 934.349 | 843.226 | 773.057 | 679.11 | 594.598 |
Gross Profit
| 1,178.123 | 1,242.538 | 988.599 | 823.695 | 808.913 | 715.994 | 536.51 | 2,649.017 | 451.572 | 419.406 | 2,122.441 | 342.722 | 290.433 | 256.31 | 231.404 | 160.182 | 153.695 | 138.928 |
Gross Profit Ratio
| 0.264 | 0.311 | 0.307 | 0.292 | 0.297 | 0.294 | 0.238 | 0.622 | 0.227 | 0.222 | 0.61 | 0.225 | 0.216 | 0.215 | 0.215 | 0.172 | 0.185 | 0.189 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 11.751 | 10.081 | 8.776 | 5.243 | 8.581 | 9.937 | 4.159 | 3.418 | 51.741 | 47.496 | 3.499 | 35.431 | 29.544 | 24.295 | 25.311 | 20.829 | 19.416 | 16.874 |
Selling & Marketing Expenses
| 221.042 | 210.06 | 170.888 | 143.763 | 152.4 | 131.303 | 131.108 | 160.499 | 403.658 | 377.619 | 107.213 | 277.191 | 234.866 | 202.371 | 162.611 | 133.931 | 111.59 | 103.277 |
SG&A
| 1,035.159 | 220.141 | 179.664 | 149.006 | 160.981 | 141.24 | 135.267 | 163.917 | 455.399 | 425.115 | 110.712 | 312.622 | 264.41 | 226.666 | 187.922 | 154.76 | 131.006 | 120.151 |
Other Expenses
| 0.379 | 884.672 | 705.981 | 580.518 | 520.73 | 1.064 | 0.127 | 0.126 | 0.084 | -86.989 | 0.033 | -49.223 | -38.385 | -23.972 | -1.574 | -2.87 | -0.743 | -1.629 |
Operating Expenses
| 1,035.159 | 1,104.813 | 885.645 | 729.524 | 681.711 | 605.388 | 441.883 | 436.572 | 361.013 | 338.126 | 310.214 | 263.399 | 226.025 | 202.694 | 186.348 | 151.89 | 130.263 | 118.522 |
Operating Income
| 142.964 | 149.011 | 121.618 | 77.858 | 117.002 | 111.616 | 104.275 | 104.892 | 62.001 | 61.51 | 71.299 | 79.323 | 51.569 | 53.616 | 48.078 | 10.169 | 17.569 | 18.657 |
Operating Income Ratio
| 0.032 | 0.037 | 0.038 | 0.028 | 0.043 | 0.046 | 0.046 | 0.025 | 0.031 | 0.033 | 0.02 | 0.052 | 0.038 | 0.045 | 0.045 | 0.011 | 0.021 | 0.025 |
Total Other Income Expenses Net
| -51.38 | -70.581 | -38.379 | -24.554 | -36.161 | -18.995 | -30.33 | -32.18 | 72.47 | -16.865 | -6.128 | -14.729 | 0 | -10.386 | 0 | 0 | 0 | 0 |
Income Before Tax
| 91.584 | 78.43 | 83.239 | 53.304 | 80.841 | 92.621 | 73.945 | 72.712 | 62.001 | 61.51 | 71.299 | 64.594 | 51.569 | 43.23 | 48.078 | 10.169 | 17.569 | 18.657 |
Income Before Tax Ratio
| 0.021 | 0.02 | 0.026 | 0.019 | 0.03 | 0.038 | 0.033 | 0.017 | 0.031 | 0.033 | 0.02 | 0.042 | 0.038 | 0.036 | 0.045 | 0.011 | 0.021 | 0.025 |
Income Tax Expense
| -1.321 | -7.915 | 3.813 | -2.847 | 4.086 | 17.639 | 14.147 | 19.653 | 16.733 | 12.151 | 15.154 | 17.489 | 14.147 | 12.457 | 11.366 | 3.521 | 5.456 | 5.59 |
Net Income
| 92.905 | 86.345 | 79.426 | 56.151 | 76.755 | 74.982 | 59.798 | 53.059 | 45.268 | 49.359 | 56.145 | 47.105 | 37.422 | 30.773 | 29.697 | 9.689 | 14.173 | 14.402 |
Net Income Ratio
| 0.021 | 0.022 | 0.025 | 0.02 | 0.028 | 0.031 | 0.026 | 0.012 | 0.023 | 0.026 | 0.016 | 0.031 | 0.028 | 0.026 | 0.028 | 0.01 | 0.017 | 0.02 |
EPS
| 0.62 | 0.58 | 0.53 | 0.37 | 0.57 | 0.55 | 0.43 | 0.38 | 0.33 | 0.36 | 0.41 | 0.34 | 0.27 | 0.22 | 0.21 | 0.07 | 0.1 | 0.1 |
EPS Diluted
| 0.62 | 0.58 | 0.53 | 0.37 | 0.57 | 0.55 | 0.43 | 0.38 | 0.33 | 0.36 | 0.41 | 0.34 | 0.27 | 0.22 | 0.21 | 0.07 | 0.1 | 0.1 |
EBITDA
| 343.118 | 333.579 | 279.392 | 195.635 | 212.339 | 131.273 | 110.947 | 112.934 | 98.602 | 95.536 | 84.865 | 88.076 | 71.518 | 66.26 | 51.904 | 14.282 | 23.432 | 20.406 |
EBITDA Ratio
| 0.077 | 0.084 | 0.087 | 0.069 | 0.078 | 0.054 | 0.049 | 0.027 | 0.05 | 0.051 | 0.024 | 0.058 | 0.053 | 0.056 | 0.048 | 0.015 | 0.028 | 0.028 |